Neuronetics Inc (STIM)
0.75
-0.03
(-3.85%)
USD |
NASDAQ |
Sep 27, 16:00
0.7875
+0.04
(+5.00%)
After-Hours: 20:00
Neuronetics SG&A Expense (Annual): 72.74M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 72.74M |
December 31, 2022 | 75.50M |
December 31, 2021 | 63.30M |
December 31, 2020 | 50.80M |
Date | Value |
---|---|
December 31, 2019 | 60.45M |
December 31, 2018 | 51.93M |
December 31, 2017 | 36.47M |
December 31, 2016 | 28.72M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
50.80M
Minimum
2020
75.50M
Maximum
2022
64.56M
Average
63.30M
Median
2021
SG&A Expense (Annual) Benchmarks
Quest Diagnostics Inc | 1.642B |
Delcath Systems Inc | 22.11M |
Star Equity Holdings Inc | 14.54M |
CytoSorbents Corp | 37.87M |
Progyny Inc | 176.62M |